Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

11,911 studies for “type 2 diabetes”

Effect of Digital-Supported Foot Care Education in Individuals With Type 2 DiabetesNot Yet Recruiting
NCT07813676NAUpdated Sep 10, 2026
Sponsor: Siirt University
Type 2 Diabetes Mellitus (T2DM)
Turkey (Türkiye)
A Three-part First-in-human Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GUB-UCN2 in Healthy Lean and Obese Participants and Participants With T2DRecruiting
NCT07702890Phase 1, Phase 2Updated Sep 10, 2026
Sponsor: Gubra A/S
Obesity · Type 2 Diabetes
Germany
A Twelve-Week Pilot Study Evaluating the Usability and Preliminary Effects of SugarVita 2.0 in Adults With Type 2 DiabetesRecruiting
NCT07812623NAUpdated Sep 10, 2026
Sponsor: Maxima Medical Center
Diabetes Mellitus · Diabetes Mellitus Type 2
Netherlands
Community-based, eHealth Supported Type 2 Diabetes Care by Lay Village Health Workers in Rural LesothoActive Not Recruiting
NCT05743387NAUpdated Sep 10, 2026
Sponsor: University Hospital, Basel, Switzerland
Type 2 Diabetes Mellitus (DM)
Lesotho, Switzerland
Susceptibility to Infectious Diseases in ObesityRecruiting
NCT05975541N/AUpdated Sep 10, 2026
Sponsor: Azienda Ospedaliero Universitaria Maggiore della Carita
Obesity · Type2diabetes · Gut Microbiota · Chronic Disease
Italy
Endoscopic Band Ligation for Type 2 Diabetes Mellitus (ENDOBAND-DM)Not Yet Recruiting
NCT07117721NAUpdated Sep 10, 2026
Sponsor: El Katib Hospital
Type 2 Diabetes Mellitus (T2DM)
Effects of VLCKD in Metabolic SyndromeActive Not Recruiting
NCT05275608NAUpdated Sep 10, 2026
Sponsor: Azienda Ospedaliero Universitaria Maggiore della Carita
Diabetes Mellitus, Type 2 · Non-alcoholic Fatty Liver Disease · Obesity · Metabolic Syndrome
Italy
A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral NeuropathyCompleted
NCT06797869Phase 2Updated Sep 10, 2026
Sponsor: Novo Nordisk A/S
Diabetes Mellitus, Type 2 · Diabetic Peripheral Neuropathy
United States, Canada, Denmark, France, Norway +2 more
Fingolimod for Type 2 Diabetes MellitusRecruiting
NCT05307731Phase 4Updated Sep 10, 2026
Sponsor: General Hospital of Shenyang Military Region
Diabetes Mellitus, Type 2
China
Optimization of Basal Insulin During Ramadan Fasting in Type 2 Diabetic Patients: Comparison Between DAR Recommendations and the Carbohydrate Fasting Test & Metabolic and Inflammatory ConsequencesActive Not Recruiting
NCT06826547EARLY_Phase 1Updated Sep 10, 2026
Sponsor: University Tunis El Manar
Diabetes Mellitus, Type 2 Treated With Insulin · Fasting, Intermittent · Ramadan Fasting · Inflammatory Markers
Tunisia
A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 DiabetesRecruiting
NCT07670416Phase 3Updated Sep 10, 2026
Sponsor: Hoffmann-La Roche
Obesity · Overweight · Type 2 Diabetes Mellitus (T2DM)
China
Heart-Kidney-Diabetes Multidisciplinary Care MOdels for CardiovascuLar Health In Patients With Chronic Kidney DiSease and Diabetes: A PragmaTIC Cluster Randomized Controlled Trial (HOLISTIC)Not Yet Recruiting
NCT07811427Phase 4Updated Sep 10, 2026
Sponsor: Baim Institute for Clinical Research
Chronic Kidney Disease · Type II Diabetes
A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 DiabetesActive Not Recruiting
NCT05791201Phase 1, Phase 2Updated Sep 10, 2026
Sponsor: Vertex Pharmaceuticals Incorporated
Type 1 Diabetes
United States, Canada, Germany, Italy, Netherlands +2 more
Adding SGLt2 Inhibitors to Patients With Type 2 DiabetesCompleted
NCT06268977Phase 4Updated Sep 10, 2026
Sponsor: Assiut University
Type 2 Diabetes
Egypt
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes MellitusRecruiting
NCT07776509Phase 3Updated Sep 10, 2026
Sponsor: AstraZeneca
Obesity or Overweight · Weight-Related Comorbidity · With/Without Diabetes Mellitus, Type 2
United States, Argentina, Brazil, Canada, China +6 more
Metabolic and Immunoinflammatory Profiles in Adults With Newly Diagnosed DiabetesCompleted
NCT07522502N/AUpdated Sep 10, 2026
Sponsor: West Kazakhstan Marat Ospanov Medical University
Diabetes Mellitus, Type 2 · Autoimmune Diabetes
Kazakhstan
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DMRecruiting
NCT07667803Phase 3Updated Sep 9, 2026
Sponsor: AstraZeneca
Weight Management
United States, Argentina, Australia, Brazil, Canada +14 more
Integrated Diabetes and Oral Health Care in OmanNot Yet Recruiting
NCT07809477NAUpdated Sep 9, 2026
Sponsor: Oman Ministry of Health
Type 2 Diabetes Mellitus · Periodontitis · T2DM · Periodontal Disease
Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATGRecruiting
NCT07216391Phase 2Updated Sep 9, 2026
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type 1 Diabetes Mellitus
United States
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 DiabetesRecruiting
NCT07282613Phase 3Updated Sep 9, 2026
Sponsor: Novo Nordisk A/S
Diabetes Mellitus, Type 2
United States, Argentina, Brazil, Colombia, India +5 more
Effectiveness of Shared Decision Making（SDM）on Patients With Poor Control Type 2 DiabetesCompleted
NCT07810647NAUpdated Sep 9, 2026
Sponsor: Fooyin University
Diabetes Mellitus, Type 2
Taiwan
Postprandial Effect of Isocaloric Challenge Meals Enriched With Indigenous Fruits and Vegetables on Glucose Metabolism in Individuals With Type 2 Diabetes in Wakiso District, UgandaCompleted
NCT07295600NAUpdated Sep 9, 2026
Sponsor: KU Leuven
Type 2 Diabetes · Cardiometabolic Health
Uganda
Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 DiabetesRecruiting
NCT05153070Phase 2Updated Sep 9, 2026
Sponsor: Assistance Publique - Hôpitaux de Paris
Type 1 Diabetes
France
iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic DiseasesRecruiting
NCT03549754N/AUpdated Sep 9, 2026
Sponsor: AstraZeneca
Type 2 Diabetes · Hypertension · Chronic Kidney Disease · Heart Failure
Brazil, Chile, Costa Rica, Côte d’Ivoire, Egypt +15 more
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)Recruiting
NCT07296484Phase 2Updated Sep 9, 2026
Sponsor: Sparrow Pharmaceuticals
Type 2 Diabetes · Cortisol Excess
United States

11,911 studies found